Medizinische Universität Graz - Research portal
Holzer Michael |
Presentations at scientific and public conferences
Matzer, I; Kiessling, M; Voglhuber, J; Trummer-Herbst, V; Sattler, S; Holzer, M; Zirlik, A; Ljubojevic-Holzer, S;
Unraveling Myocardial Immune Activation in Hypertensive Dahl Salt-Sensitive Rats
Young Investigator Retreat 2024 - BioTechMed Graz; June 24-26, 2024; Seggau, AUSTRIA. 2024.
[Poster]
Voglhuber, J; Matzer, I; Djalinac, N; Kiessling, M; Trummer-Herbst, V; Holzer, M; Zirlik, A; Holzer, S
Spatio-specific CaMKII activation in cardiomyocytes from hypertensive Dahl salt-sensitive rats.
BIOPHYS J. 2023; 122(3):236A-236A.
[Poster]
Web of Science
PubMed
Matzer, I; Voglhuber, J; Djalinac, N; Trummer-Herbst, V; Kiessling, M; Fernandes, HC; Rech, L; Holzer, M; Ljubojevic-Holzer, S
beta 1-adrenergic receptor signaling during early and late hypertensive cardiac remodeling
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):138-139.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science
Matzer, I; Voglhuber, J; Djalinac, N; Trummer-Herbst, V; Kiessling, M; Hollnagel, CF; Rech, L; Holzer, M; Ljubojevic-Holzer, S
Beta-1 adrenergic receptor signalling during early and late hypertensive cardiac remodelling
CARDIOVASC RES. Abstract Book of: 6th Congress of the ESC Council on Basic Cardiovascular Science. 2022; 118(SUPPL 1):-6th Congress of the ESC Council on Basic Cardiovascular Science: Frontiers in CardioVascular Biomedicine 2022; APR 29 - MAI 1, 2022; Budapest, HUNGARY.
Doi: 10.1093/cvr/cvac066.094
[Poster]
Web of Science
FullText
FullText_MUG
Voglhuber, J; Holzer, M; Radulovic, S; Thai, PN; Djalinac, N; Matzer, I; Wallner, M; Bugger, H; Zirlik, A; Leitinger, G; Dedkova, EN; Bers, DM; Ljubojevic, S
Functional remodeling of perinuclear mitochondria alters nucleoplasmic Ca2+ signaling in heart failure
BIOPHYS J. 2022; 121(3):509A-510A.
[Oral Communication]
Web of Science
Voglhuber, J; Holzer, M; Radulovic, S; Thai, PN; Djalinac, N; Matzer, I; Wallner, M; Bugger, H; Zirlik, A; Leitinger, G; Dedkova, EN; Bers, DM; Ljubojevic-Holzer, S
Functional remodeling of perinuclear mitochondria alters nucleoplasmic Ca2+signaling in heart failure
CARDIOVASC RES. 2022; 118(SUPPL 1):
Doi: 10.1093/cvr/cvac066.027
[Oral Communication]
Web of Science
FullText
FullText_MUG
Voglhuber, J; Holzer, M; Radulovic, S; Thai, PN; Djalinac, N; Matzer, I; Wallner, M; Bugger, H; Zirlik, A; Leitinger, G; Dedkova, EN; Bers, DM; Ljubojevic-Holzer, S
Perinuclear mitochondria are functionally affected in heart failure and alter nucleoplasmic Ca2+signaling
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):156-157.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science
Matzer, I; Voglhuber, J; Djalinac, N; Trummer-Herbst, V; Kiessling, M; Fernandes-Hollnagel, C; Rech, L; Holzer, M; Ljubojevic-Holzer, S
β-adrenergic receptor signalling during early and late hypertensive
cardiac remodelling
Young Investigator Retreat 2021 - BioTechMed Graz; NOV 9 - 10, 2021; Seggau, AUSTRIA;. 2021.
[Oral Communication]
Voglhuber, J; Holzer, M; Radulovic, S; Thai, PN; Djalinac, N; Matzer, I; Wallner, M; Bugger, H; Zirlik, A; Leitinger, G; Dedkova, EN; Bers, DM; Ljubojevic-Holzer, S;
Functional remodeling of perinuclear mitochondria alters nucleoplasmic Ca2+ signaling in heart failure
3. Grazer Herzkreislauftage; SEP 17 - 19, 2021; Graz, Austria. 2021.
[Poster]
Voglhuber, J; Matzer, I; Djalinac, N; Trummer-Herbst, V; Kiessling, M; Zhang, F; Fernandes-Hollnagel, C; Rech, L; Holzer, M; Madl, T; Ljubojevic-Holzer, S;
Crosstalk between PRMT1 and CaMKII signaling in cardiomyocytes from hypertensive Dahl salt-sensitive rats
Young Investigator Retreat 2021 - BioTechMed Graz; NOV 9 - 10, 2021; Seggau, AUSTRIA. 2021.
[Oral Communication]
Emrich, I; Trieb, M; Scharnagl, H; Pregartner, G; Holzer, M; Rogacev, K; Bohm, M; Heine, GH; Marsche, G
HDL Subclasses as a Prognosis Marker of newly occurring cardiovascular Events in chronic Kidney Disease.
INTERNIST. Abstracts zum 126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. 2020; 61(SUPPL 1):S7-S8.-126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.; APR 25-28, 2020; Wiesbaden, GERMANY.
[Oral Communication]
Web of Science
Holzer, M; Birner-Gruenberger, R; Marsche, G
The proteome of HDL2/3 is not as complex as previously anticipated
8th IAS workshop on HDL ; SEP 25-27, 2019; Valencia, Spain. 2019.
[Poster]
Holzer, M; Marsche, G
HDL research: From the wild west to reproducibility
IAS - HDL workshop 2019: Structure, novel functions and therapeutic applications; SEP 25-27, 2019; Valencia, Spain. 2019.
[Poster]
Trakaki, A; Sturm, GJ; Pregartner, G; Scharnagl, H; Eichmann, TO; Trieb, M; Knuplez, E; Holzer, M; Stadler, JT; Heinemann, A; Sturm, EM; Marsche, G
Role of high-density lipoprotein composition and function in allergy
DK-MOLIN Annual Retreat; APR 11-13; Schloss Seggau, Leibnitz, AUSTRIA. 2019.
[Oral Communication]
Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G.
Secretory phospholipase A2 modified HDL potently inhibits platelet activation
9th ÖGMBT Annual Meeting; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Marsche, G; Holzer, M; Curcic, S
SECRETORY PHOSPHOLIPASE A2 MODIFIED HIGH-DENSITY LIPOPROTEIN POTENTLY SUPPRESSES PLATELET ACTIVATION
ATHEROSCLEROSIS. 2017; 263: E94-E94.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC.
Doi: 10.1016/j.atherosclerosis.2017.06.306
[Oral Communication]
Web of Science
FullText
FullText_MUG
Trieb, M; Büttner, P; Kornej, J; Holzer, M; Husser, D; Marsche, G
High-density lipoprotein subclass distribution and function are profoundly altered in atrial fibrillation
Cardioflame; NOV 23, 2017; Graz, AUSTRIA. 2017.
[Poster]
Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL suppresses platelet activation and platelet-leukocyte crosstalk
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Kober, A; Chirackal Manavalan, AP; Fanaee Danesh, E; Zandl, M; Tam-Ammersdorfer, C; Albrecher, N; Marsche, G; Holzer, M; Kostner, G; Holmer, A; Dahlbäck, B; Panzenboeck, U
ATP-BINDING CASSETTE TRANSPORTER A1 AND APOLIPOPROTEIN M ARE "NOVEL PLAYERS" IN CHOLESTEROL TRANSPORT AT THE BLOOD-BRAIN BARRIER.
Proceedings of the 2016 Alzheimer's Disease Congress. 2016; -THE 2016 ALZHEIMER’S DISEASE CONGRESS; JUN 7-9,2016; London, UK.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Holzer, M; Marsche, G
Liver disease alters HDL composition and function
EAS Congress 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Taschler, U; Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Liver Disease Alters HDL Composition, Metabolism and Function
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7, 2016; Nashville, USA. 2016.
[Poster]
Appierto, M; Trieb, M; Pasterk, L; curcis, S; Holzer, M; Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease
International Student Congress 2015; JUN 4-6, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto,M;Trieb, M;Pasterk, L; Curcic, S; Holzer, M; Frank, S; Marsche, G;
Maturation of HDL is impaired in cardiovascular disease
AAS meeting 2015; MAY 8-9 , 2015; St. Gilgen. 2015.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Neutrophil effector responses are fully suppressed by secretory phospholipase A2-modified HDL
21st Scientific Symposium of the Austrian Pharmacological Society (APHAR)
; SEP 16-18, 2015; Graz, AUSTRIA. 2015.
[Poster]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 shows potent anti-inflammatory effects on neutrophils
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Marsche, G; Schilcher, G; Rosenkranz, A; Holzer, M
Uremia alters HDL metabolism, composition and function
ISBN: 978-3-200-04352-7. 2015; -Biomarkers in Human Health and Disease; OKT 9-10,2015; Graz.
[Oral Communication]
Marsche, G; Schilcher, G; Scharnagl, H; Stojakovic, T; Rosenkranz, A; Holzer M
Dialysis modalities, HDL metabolism and function
Symposium- Biomarker und Nierenerkrankungen ; JAN 16-17, 2015; Mannheim, GERMANY, 2014. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, R; Holzer, M; Pasterk, L; Taschler, U; Heinemann, A; Marsche, G
Cirrhosis alters HDL metabolism and function
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Metrics of HDL functions are markedly impaired in cirrhosis
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Holzer, M; Marsche, G
Liver cirrhosis, high–density lipoproteins and anti-inflammatory and endothelial regenerative activities of serum
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G
Maturation of HDL is impaired in cardiovascular disease.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G.
HDL, inflammation and cardiovascular disease
DK-MOLIN Retreat ; OKT 29-30 , 2014; Seggau, AUSTRIA. 2014.
[Oral Communication]
Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine.
Doctoral Day 2014; DEZ 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Frank, S; Opresnik, S; Rao, SP; Hrzenjak, A; Hallstrom, S; Kozina, A; Sreckovic, I; Wadsack, CH; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H
ENDOTHELIAL LIPASE ATTENUATES VASORELAXING CAPACITY OF HDL
ATHEROSCLEROSIS. 2014; 235(2): E45-E45.
Doi: 10.1016/j.atherosclerosis.2014.05.102
[Poster]
Web of Science
FullText
FullText_MUG
Holzer, M; Schilcher, G; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G
Hemodialysis and peritoneal dialysis differentially affect HDL composition and function
Symposium on Cardiac and Vascular Stiffness; SEP 26-27, 2014; Seggau, AUSTRIA. 2014.
[Poster]
Holzer, M; Schilcher, M; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G
Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL; MAR 24-26, 2014; Rom, Italy.
[Poster]
Kopecky, C; Holzer, M; Birner-Gruenberger, R; Marsche, G; Saemann, M
Molecular Composition and Function of High-Density Lipoprotein Is Uniquely Altered After Kidney Transplantation.
AM J TRANSPLANT. 2014; 14: 565-565.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Kopecky, C; Holzer, M; Birner-Gruenberger, R; Marsche, G; Saemann, M;
Molecular Composition and Function of High-Density Lipoprotein Is Uniquely Altered After Kidney Transplantation..
TRANSPLANTATION. 2014; 98: 565-565.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
Doi: 10.1097/00007890-201407151-01897
[Poster]
Web of Science
FullText
FullText_MUG
Kopecky, M; Haidinger, M; Birner-Grünberger, R; Kaltenecker, C; Marsche, G; Holzer, M; Saemann, MD
The molecular composition and function of HDL is uniquely altered after kidney transplantation
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL - Abstract Book; MAR 24-26, 2014; Rom, Italy.
[Poster]
Kozina, A; Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial lipase attenuates vasorelaxing capacity of HDL
Book of Abstracts. 2014; -21st Annual Meeting of the Austrian Atherosclerosis Society; May 9-10, 2014; St. Gilgen/ Wolfgangsee.
[Oral Communication]
Mader, JK; Leelarathna, L; Dellweg, S; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Holzer, M; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R
Tag und Nacht automatisierte Closed-Loop Insulintherapie bei Erwachsenen mit Typ 1 Diabetes: eine randomisierte Crossover-Studie in 3 europäischen Zentren
Wiener Klinische Wochenschrift. 2014; 126(S04):S180-S180.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Marsche, G; Holzer, M; El-Gamal, D
The urea decomposition product cyanate promotes endothelial dysfunction
Symposium- Biomarker und Nierenerkrankungen
; JAN 17-18, 2014; Würzburg, GERMANY. 2014.
[Poster]
Marsche, G; Wolf, P; Holzer, M
Anti-psoriatic therapy recovers HDL composition and function independent of of serum HDL-cholesterol levels
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL; MAR 24-26, 2014; Rom, Italy.
[Poster]
Opresnik, S; Rao, S.P; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Gruenberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial Lipase Attenuates Vasorelaxing Capacity of HDL.
keine. 2014; -7th IAS Workshop on HDL; März 24-26, 2014; Rom, Italien.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL shows potent anti-inflammatory effects on neutrophils
ZMF (Center for Medical Research) 10th Anniversary; JUL 17-18, 2014; Graz, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
4th European Lipidomic Meeting; SEP 22-24; Graz, AUSTRIA. 2014.
[Poster]
Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche
Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
20th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 26-27; Innsbruck, Austria. 2014.
[Poster]
Curcic, S; Holzer, M; Frank, S; Frei, R; Heinemann, A; Marsche, G;
Secretory phospholipase A2 drives reprogramming of neutrophils
Doctoral Day 2013; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Curcic, S; Holzer, M; Heinemann, A; Marsche, G
Acute-phase secretory phospholipases have a potent antiinflammatory activity.
Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR); SEP 16-19, 2013; Vienna, AUSTRIA. 2013.
[Oral Communication]
Holzer, M; Wolf, P; Inzinger, M; Trieb, M; Curcic, S; Pasterk, L; Weger, W; Heinemann, A; Marsche, G.
Anti-psoriatic therapy recovers high-density lipoprotein composition and function
Intrinsic Activity. 2013; 1(1):-Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR) ; SEP 16-19, 2013; Vienna, AUSTRIA.
[Poster]
FullText
Kober, AC; Chirackal Manavalan, AP; Marsche, G; Holzer, M; Grünberger, RM; Kostner, G; Holmer, A; Dahlbäck, B; Panzenboeck, U
ATP-binding Cassette Transporter G1 and Apolipoprotein M Are 'Novel Players' in Cholesterol Transport at the Blood-brain Barrier
11th International Conference on Alzheimers and Parkinsons Diseases and related neurological disorders; MARCH 5-10, 2013; Florence, Italy. 2013.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, M
Dysfunctional High-Density Lipoprotein as a Novel Cardiovascular Risk Factor after Kidney Transplantation.
Nephrology Dialysis Transplantation Supplement. 2013; 13: 413-413.-50th ERA-EDTA Congress; MAY 18-21, 2013; Istanbul.
[Poster]
Web of Science
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, M.
Dysfunctional High-Density Lipoprotein as a Novel Cardiovascular Risk Factor after Kidney Transplantation
AMERICAN JOURNAL OF TRANSPLANTATION Supplement. 2013; -American Transplant Congress; MAY 18-22; Seattle, USA.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, MD
THE MOLECULAR COMPOSITION AND FUNCTION OF HIGH-DENSITY LIPOPROTEIN IS UNIQUELY ALTERED AFTER KIDNEY TRANSPLANTATION
TRANSPL INT. . 2013; 26: 242-242.
[Poster]
Web of Science
Kopecky, C; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Säemann, MD
DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN AS A NOVEL CARDIOVASCULAR RISK FACTOR AFTER KIDNEY TRANSPLANTATION
ATHEROSCLEROSIS SUPPLEMENTS. 2013. 2013; -European Atherosclerosis Society Congress; JUN 2-5,2013; Lyon, FRANCE.
[Poster]
Kopecky, C; Haidinger, M; Kaltenecker, C; Birner-Grünberger, R; Marsche, G; Holzer, M; Saemann, M
The molecular composition and function of high-density lipoprotein is uniquely altered after kidney transplantation
9th YSA PhD-Symposium Abstract_Book_2013. 2013; -9th YSA PhD-Symposium; JUN 19-20, 2013; Vienna, AUSTRIA.
[Poster]
Kopecky, CM; Haidinger, M; Kaltenecker, C; Antlanger, M; Marsche, G; Holzer, M; Kovarik, J; Werzowa, J; Hecking, M; Saemann, MD;
DYSFUNCTIONAL HIGH-DENSITY LIPOPROTEIN AS A NOVEL CARDIOVASCULAR RISK FACTOR AFTER KIDNEY TRANSPLANTATION.
NEPHROL DIALYSIS TRANSPLANT. 2013; 28: 281-282.-50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress; MAY 18-21, 2013; Istanbul, TURKEY.
[Poster]
Web of Science
Marsche, G; Wolf, P; Holzer, M
PSORIASIS ALTERS HDL COMPOSITION AND FUNCTION
ATHEROSCLEROSIS SUPPLEMENTS. 2013; -European Atherosclerosis Society Congress; JUN 2-5,2013; Lyon, FRANCE.
[Poster]
Opresnik, S; Rao, SP; Hrzenjak, A; Hallström, S; Kozina, A; Sreckovic, I; Wadsack, Ch; Holzer, M; Marsche, G; Birner-Grünberger, R; Stojakovic, T; Scharnagl, H; Frank, S
Endothelial lipase attenuates vasorelaxing capacity of HDL
43. Jahrestagung des Arbeitskreises ''Klinischer Lipidstoffwechsel'' Maikammer 2013; NOV 28-30, 2013; Maikammer, Deutschland. 2013.
[Oral Communication]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
Doctoral Day; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
1st Retreat, Doctoral College-Molecular Fundamentals of Inflammation; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; Marsche, G;
HOCl-oxidation converts plasma albumin into an irreversible HDL-receptor antagonist.
Doctoral Day 2012; DEC 7, 2012; Graz, Austria. 2012.
[Poster]
Binder, V; Ljubojevic, S; Holzer, M; El-Gamal, D; Dirnberger, S; Pieske, B; Marsche, G;
HOCl-oxidation converts plasma albumin into an irreversible HDL-receptor antagonist
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEPT 20-21, 2012; Graz, Austria. 2012.
[Poster]
Curcic, S;Holzer, M; Schilcher, G; Rosenkranz, A; Stojakovic,T;Heinemann, A; Marsche, G;
Chronic kidney disease alters anti-inflammatory properties of HDL.
Doctoral Day 2012; Dec 7, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
El-Gamal, D; Holzer, M; Gauster, M; Binder, V; Heinemann, A; Marsche, G
Cyanate triggers vascular endothelial inflammation
Keystone Symposium Conference on Molecular Basis of Vascular Inflammation and Atherosclerosis (C7). 2012; -Keystone Symposium ; MAR 25-30, 2012; Big Sky, Montana, USA.
[Poster]
El-Gamal, D;Holzer, M; Gauster, M; Binder, V; and Marsche, G:
Cyanate, a novel inflammatory trigger, induces endothelial dysfunction.
18th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEPT 20-21, 2012; Graz, Austria. 2012.
[Poster]
Holzer, M; Birner-Grünberger, R; Stojakoviæ, T; El-Gamal, D; Binder, V; Wadsack, C; Heinemann, A; Marsche, G.
Uremia alters HDL composition and cholesterol efflux capacity
BMC Pharmacology & Toxicology Supplements. 2012; 13(1):-18th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 20-21, 2012; Graz, Austria.
[Oral Communication]
FullText
Holzer, M; Curcic, S; El-Gamal, D; Binder, V; Schilcher, G; Rosenkranz, A; Marsche, G
Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
ATHEROSCLEROSIS SUPPLEMENTS. 2012; -European Atherosclerosis Society Congress; MAI 25-28, 2012; MAILAND.
[Poster]
FullText
Manavalan, APC, Kober A, Schweinzer C, Scholler M, Becker T, Hasslitzer K, Marsche G, Holzer M, Kostner G, Birner-Gruenberger R, Stefulj J, Jauhiainen M, Panzenboeck U
Liver X receptor activation in cerebrovascular endothelial cells regulates genes involved in HDL metabolism at the blood brain barrier
Proceedings of the 4th International Graz Symposium on Lipid and Membrane Biology. 2012; -4th International Symposium on Lipid and Membrane Biology; Mar 8-10; Graz, Austria.
[Poster]
FullText
Marsche,G; El-Gamal,D; Binder,V; Curcic,S; Holzer,M;
Myeloperoxidase favors lipoprotein carbamylation: Novel pathways generating dysfunctional high-density lipoprotein
Meeting Abstract; ATHEROSCLEROSIS SUPPLEMENTS. 2012; -80th European Atherosclerosis Society Congress; MAI 28-28,2012; Milan, ITALY.
[Oral Communication]
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; and Marsche, G
Uremic albumin blocks reverse cholesterol transfer: role of lysine modifications
Meeting abstract from 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR). . 2011; 11(S2):-17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Joint meeting with the Hungarian Society of Experimental and Clinical Pharmacology (MFT); Sept 29-30, 2011; Innsbruck, AUSTRIA.
[Poster]
FullText
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; and Marsche, G;
Uremic albumin blocks reverse cholesterol transfer: Role of lysine modifications
Doctoral Day 2011; NOV 4, 2011; Graz, AUSTRIA. 2011.
[Poster]
El-Gamal, D; Holzer, M; Binder, V; Dirnberger, S; Heinemann, A; Marsche, G
Urea induces intercellular adhesion molecule-1 expression
Meeting abstract in the 17th Scientific Symposium of the Austrian Pharmacological Society (APHAR).. 2011; 11(S 2):-17th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Joint Meeting with the Hungarian Society for Experimental and Clinical Pharmacology (MFT); Sept 29-30, 2011; Innsbruck, Austria.
[Oral Communication]
FullText
El-Gamal, D; Holzer, M; Gauster, M; Schicho, R ; Binder, V; Heinemann, A; Marsche, G
Cyanate is a novel inducer of endothelial intercellular adhesion molecule-1 (ICAM-1)
Doctoral Day; 4 Nov, 2011; Graz, Austria. 2011.
[Poster]
Holzer, M; Birner-Gruenberger, R; Binder, V; El-Gamal, D; Marsche, G
PROTEOMIC ALTERATIONS OF HDL FROM HEMODIALYSIS PATIENTS ARE ASSOCIATED WITH IMPAIRED CHOLESTEROL EFFLUX CAPACITY
ATHEROSCLEROSIS SUPP. 2011; 12(1):39-39.-79th Congress of the European-Atherosclerosis-Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN.
Doi: 10.1016/S1567-5688(11)70174-X
[Poster]
Web of Science
FullText
FullText_MUG
Holzer, M; Birner-Gruenberger, R: El-Gamal, D; Binder, V; Marsche, G
HDL from hemodialysis patients carries a unique protein and lipid cargo associated with impaired cholesterol efflux capacity
Gordon Research Conference on Atherosclerosis; JUN 19-24, 2011; Newport, USA. 2011.
[Poster]
Holzer, M; Birner-Gruenberger, R: El-Gamal, D; Binder, V; Marsche, G
HDL from hemodialysis patients carries a unique protein and lipid cargo associated with impaired cholesterol efflux capacity
EAS 2011 - Congress Abstracts. 2011; -79th European Atherosclerosis Society Congress; JUN 26-29; Gothenborg, SWEDEN.
[Poster]
Holzer, M; Birner-Gruenberger, R; Stojakovic, T; El-Gamal, D;
Binder, V; Wadsack, C; Heinemann, A; Marsche, G
Uremia Alters HDL Composition and Function
Doctoral Day 2011; NOV 4, 2011; GRAZ, AUSTRIA. 2011.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; El-Gamal, D; Binder, V; Heinemann, A; Marsche, G
Protein carbamylation renders HDL dysfunctional
7th Human Peroxidase Meeting; MAY 22-25. 2011; Brussel, Belgium. 2011.
[Oral Communication]
Ljubojevic, S; Sedej, S; Holzer, M; Marsche, G; Marijanski, V; Kockskaemper, J; Pieske, B
Subcellular localization and expression levels of TRPC3, ORAI1, and STIM1 in normal and hypertrophied mouse heart
EUR HEART J SUPPL. 2011; 13(A):A37-A37.-10th International Conference of Non-Invasive Cardiovascular Imaging; MAY 15-18, 2011; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
Ljubojevic, S; Sedej, S; Holzer, M; Marsche, G; Marijanski, V; Kockskämper, J; Pieske, B
Expression and Subcellular Localization of TRPC3, Orai1, and STIM1 after Pressure Overload-Induced Hypertrophy in Adult Cardiac Myocytes
Biophysical Journal, Suppl.
2011; 100(3):85a--55. Biophysical Society Meeting; MAR 4-9, 2011; Baltimore, USA.
[Poster]
Marsche, G; Gauster, M; Holzer, M
PROTEIN CARBAMYLATION RENDERS HIGH-DENSITY LIPOPROTEIN DYSFUNCTIONAL
ATHEROSCLEROSIS SUPP. 2011; 12(1):39-39.-79th Congress of the European-Atherosclerosis-Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN.
Doi: 10.1016/S1567-5688(11)70178-7
[Poster]
Web of Science
FullText
FullText_MUG
Schweinzer, C; Kober, A; Etschmaier, K; Scholler, M; Holzer, M;Marsche, G;
Sattler, W; Panzenboeck, U
Liver X receptor agonists and altered cellular cholesterol metabolism modulate APP expression in cerebromicrovascular endothelial cells.
18th ANNUAL MEETING - AAS of the Austrian Atherosclerosis Society; MAY 6-7, 2011; St. Gilgen, AUSTRIA. 2011.
[Oral Communication]
Sreckovic, I; Birner-Gruenberger, R; Philipose, S; Holzer, M; Marsche, G; Desoye, G; Lang, U; Wadsack, C
APOLIPOPROTEINS (APO) ACCOUNTS FOR THE ANTI-INFLAMMATORY FUNCTION OF FETAL HDL
PLACENTA. 2011; 32(9):A112-A112.-Meeting of the International-Federation-of-Placenta-Associations (IFPA); SEP 14-17, 2011; Geilo, NORWAY.
[Poster]
Web of Science
Binder, V; Holzer, M; El-Gamal, D; Dirnberger, S; Marsche, G
Lysine Oxidation is required for high affinity binding of albumin to the HDL receptor SR-BI
Joint ZMF and Doctoral Days 2010; Nov 5-6, 2010; Graz, Austria. 2010.
[Poster]
El-Gamal, D; Holzer, M; Binder, V; Dirnberger, S; Wadsack, C; Heinemann, A; Marsche, G
Urea Induces Intercellular Adhesion Molecule-1 Expression and Inhibits Endothelial Nitric Oxide Synthase in Human Coronary Artery Endothelial Cells.
Granted Best PhD Poster Award ''Posterpreis PhD''
Joint ZMF and Doctoral Days 2010; NOV 5-6, 2010; Graz. 2010.
[Poster]
Holzer, M; Crnkovic, S; Heinemann, A; Halilbasic, E; Olschewski, A
MOLECULAR MEDICINE PHD PROGRAM; EXPERIENCES AT MEDICAL UNIVERSITY OF GRAZ
5th ORPHEUS Conference; APRIL 8-11; VIENNA. 2010.
[Poster]
Holzer, M; Gauster, M; Binder, V; El-Gamal, D; Wadsack, C; Heinemann, A; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein
APHAR 2010; NOV 26-27; VIENNA. 2010.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; Fauler, F; Heinemann, A; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein in human atherosclerotic lesions
European Society of Cardiology Congress 2010; AUGUST 28 - SEPTEMBER 1; STOCKHOLM. 2010.
[Poster]
Holzer, M; Gauster, M; Wadsack, C; Fauler, G; Marsche, G
Cyanate transforms HDL into a pro-atherogenic lipoprotein in human atherosclerotic lesions
JOINT ZMF & DOCTORAL DAY 2010; NOV 5-6; GRAZ, AUSTRIA. 2010.
[Oral Communication]
Holzer, M; Gauster, M; Wadsack, C; Marsche, G
Cyanate selectively disrupts anti-atherogenic activities of high-density lipoprotein in human atherosclerotic lesions
EUR HEART J. 2010; 31: 250-250.
[Poster]
Web of Science
Schweinzer, C; Kober, A; Scholler, M; Etschmaier, K; Holzer, M; Marsche, G; Sattler, W; Panzenböck, U
Amyloid Precursor Protein Metabolism at the Blood-Brain Barrier is Influenced by Cholesterol and Liver X Receptor Ligands
ÖGMBT Annual Meeting 2010; SEP, 27-29, 2010; Vienna, AUSTRIA. 2010.
[Poster]
Holzer, M; Gauster, M; Birner-Gruenberger, R; Marsche, G
CARBAMYLATION RENDERS HIGH-DENSITY LIPOPROTEIN DYSFUNCTIONAL.
International Congress on Coronary Artery Disease, ICCAD; OKT 11-14, 2009; Prague, Czech Republic. 2009.
[Poster]
Holzer, M; Gauster, M; Birner-Gruenberger, R; Marsche, G
Carbamylation Impairs the Functional Integrity of High-Density Lipoprotein (HDL).
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
Holzer, M; Gauster, M;Birner-Grünberger, R; Marsche, G;
The effect of carbamylation on the functionality of high-density lipoprotein
15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 19-21, 2009; Graz, AUSTRIA. 2009.
[Poster]
FullText
Marsche, G; Frank, S; Hrzenjak, A; Holzer, M; Heinemann, A; Öttl, K
Advanced oxidation protein products are antagonists of the HDL receptor SR-BI
Circulation Research2009; 104(6):750-757.-15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; NOV 19-21, 2009; Graz, Austria. (ISBN: 0009-7330 )
[Oral Communication]
Marsche, G; Holzer, M; Wadsack, C; Frank, S; Heinemann, A
ADVANCED OXIDATION PROTEIN PRODUCTS ARE PROINFLAMMATORY MEDIATORS THAT DIRECTLY IMPAIR HDL METABOLISM.
International Congress on Coronary Artery Disease, ICCAD; OCT 11-14, 2009; Prague, Czech Republic. 2009.
[Poster]
FullText
Marsche, G; Holzer, M; Wadsack, C; Heinemann, A
Advanced Oxidation Protein Products Block the HDL Receptor SR-BI.
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
FullText
Schweinzer, C; Becker, T; Scholler, M; Etschmaier, K; Holzer, M; Marsche, G; Birner-Gruenberger, R; Sattler, W; Panzenboeck, U
Amyloid Precursor Protein Metabolism at the Blood-Brain Barrier is influenced by Cholesterol and Liver X Receptor Ligands.
7th Euro Fed Lipid Congress. Lipids, Fats and Oils - From Knowledge to Application; OCT 18-22; Graz, AUSTRIA. 2009.
[Poster]
FullText